tiprankstipranks
GlaxoSmithKline (GB:GSK)
LSE:GSK
UK Market

GlaxoSmithKline (GSK) Income Statement

1,147 Followers

GlaxoSmithKline Income Statement

Last quarter (Q4 2025), GlaxoSmithKline's total revenue was £8.62B, an increase of 6.17% from the same quarter last year. In Q4, GlaxoSmithKline's net income was £636.00M. See GlaxoSmithKline’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 32.67B£ 31.38B£ 30.33B£ 29.32B£ 24.70B
Gross Profit
£ 23.70B£ 21.90B£ 21.25B£ 19.46B£ 16.34B
Operating Expenses
£ 16.53B£ 16.24B£ 14.26B£ 12.78B£ 10.94B
Depreciation and Amortization
£ 3.78B£ 2.55B£ 2.29B£ 2.15B£ 2.12B
EBITDA
£ 11.88B£ 6.67B£ 9.14B£ 8.63B£ 6.45B
Operating Income
£ 7.17B£ 5.66B£ 6.99B£ 6.68B£ 5.41B
Other Income/Expenses
£ 232.00M£ -2.19B£ -929.00M£ -1.05B£ -1.81B
Pretax Income
£ 7.40B£ 3.48B£ 6.06B£ 5.63B£ 3.60B
Net Income
£ 5.72B£ 2.58B£ 4.93B£ 14.96B£ 4.38B
Per Share Metrics
Basic EPS
£ 1.41£ 0.63£ 1.22£ 3.71£ 1.37
Diluted EPS
£ 1.39£ 0.62£ 1.20£ 3.66£ 1.35
Weighted Average Shares Outstanding
4.05B 4.08B 4.05B 4.03B 3.20B
Weighted Average Shares Outstanding (Diluted)
4.12B 4.14B 4.11B 4.08B 3.24B
Currency in GBP

GlaxoSmithKline Earnings and Revenue History